Loan & DebtOct 30, 2026, 04:12 PM
Northwest Biotherapeutics Secures $5.5M Loan
AI Summary
Northwest Biotherapeutics, Inc. has entered into a Commercial Loan Agreement and Note for $5,505,000 with Streeterville Capital, LLC. The loan matures in 22 months, with principal and interest payments beginning after an initial 8-month interest-only period. Interest is set at 8% per annum, and there is a 10% original issue discount. The company has the option to pre-pay the loan, which would incur a 10% charge. Funds are intended for ongoing business operations.
Key Highlights
- Northwest Biotherapeutics Inc. secured a $5,505,000 commercial loan from Streeterville Capital, LLC.
- The loan has a maturity of 22 months with no repayments for the first 8 months.
- Beginning June 26, 2027, the loan will be amortized in 14 equal monthly installments.
- Interest accrues at 8% per annum with a 10% original issue discount.
- The company can pre-pay the loan at any time, subject to a 10% charge.
Price Impact
More from NWBO